NUT

Jia Luo1, Michelle Sanchez2, Elinton Lee2

  • 1Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

概括

与相比,ifosfamide化疗显示出更高的响应率,但没有改善NUT癌症的存活率. 对于这种侵袭性癌症,迫切需要有效的治疗方法,三年生存率仅为19%.